(Q36406218)

14 August 2017

1 reference

title

Problem pathogens: prevention of malaria in travellers (English)

1 reference

14 August 2017

0 references

1 reference

Carlos Franco-Paredes

series ordinal

1

1 reference

14 August 2017

José Ignacio Santos-Preciado

series ordinal

2

1 reference

14 August 2017

publication date

1 March 2006

1 reference

Lancet Infectious Diseases

14 August 2017

published in

1 reference

14 August 2017

volume

6

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

139-149

1 reference

14 August 2017

cites work

The treatment of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

New strategies for the prevention of malaria in travelers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Malaria: from prehistory to present

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

1 reference

7 January 2021

A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Phylogeny of the malarial genus Plasmodium, derived from rRNA gene sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

The economic and social burden of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

The global distribution of clinical episodes of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Antimalarial drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

The pathogenic basis of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Who needs drug prophylaxis against malaria? My personal view

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Mortality from Plasmodium falciparum malaria in travelers from the United States, 1959 to 1987.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Malaria chemoprophylaxis: when should we use it and what are the options?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Two worlds of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Malaria risk in travelers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

The risk of malaria in travellers to Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Malaria at Christmas: risks of prophylaxis versus risks of malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Malaria imported into the United Kingdom in 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Imported malaria at an inner-city hospital in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Malaria in travelers: a review of the GeoSentinel surveillance network.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Travel medicine considerations for North American immigrants visiting friends and relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Health disparities among travelers visiting friends and relatives abroad

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Health Risks Associated with Visiting Friends and Relatives in Developing Countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Adherence to travel health guidelines: the experience of Nigerian immigrants in Houston, Texas

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Effectiveness of antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Health advice and immunizations for travelers.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Use of malaria prevention measures by North American and European travelers to East Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Comparative efficacy of insect repellents against mosquito bites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

1 reference

7 January 2021

Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Delayed onset of malaria--implications for chemoprophylaxis in travelers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Travellers returning to Sweden with falciparum malaria: pre-travel advice, behaviour, chemoprophylaxis and diagnostic delay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Antimalarial drug resistance: the pace quickens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Antimalarial Drug Toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Atovaquone and proguanil for the treatment of malaria in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Mefloquine-resistant falciparum malaria on the Thai-Burmese border

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Epidemiology of drug resistance in malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Chloroquine resistance in Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Malaria Chemoprophylaxis in German Tourists: A Prospective Study on Compliance and Adverse Reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Comparison of three regimens for malaria prophylaxis in travellers to east, central, and southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Mefloquine for malaria chemoprophylaxis 1992-1998: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Chloroquine sensitivity of Plasmodium vivax in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Need for a better dosing regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Mechanism of cardiotoxicity of halofantrine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Fake artesunate in southeast Asia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Evaluation of reported malaria chemoprophylactic failure among travelers in a US University Exchange Program, 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Neurotoxicity due to antimalarial therapy associated with misdiagnosis of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Malaria chemoprophylaxis with tafenoquine: a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970410-8

7 January 2021

10.1016/S1473-3099(06)70410-8

Identifiers

DOI

1 reference

14 August 2017

1 reference